CUSP Appoints Dr. Lynn Webster as Senior Fellow

July 12, 2021

CUSP welcomes new senior fellow with focus on ensuring credible science, sound economics, and the rule of law underpin U.S. health and drug policy.

Federal Drug Policy Requires Greater Economic Balance

May 19, 2021

CUSP’s chairman tells PAINWeek that the federal government can improve drug policy by better addressing both demand for and supply of controlled medications and illicit substances.

CUSP Names Executives ‘Qualified and Ready on Day One’

December 15, 2020

Nonprofit tells Biden-Harris Transition Team that no woman has ever served as drug czar and states, “It is time for a woman to hold that position.”

DEA Expanding Surveillance of Prescription Drug Data

November 11, 2020

CUSP’s chairman discusses the impact of the new RFP from the DEA that asks software contractors to create a nationwide data system that will increase the surveillance of prescriptions.

Feds Warn of Scammers Impersonating DEA Agents

August 5, 2020
The U.S. Drug Enforcement Administration (DEA) warns doctors, pharmacists, and the public about criminals posing as DEA agents and attempting to extort money from them. CUSP’s chairman cautions that the scammers have enough knowledge of the tactics DEA is employing against controlled-medication prescribers to be able to replicate them in other situations.

NC Medical Board Leaves Patients in Limbo

February 22, 2020

CUSP’s chairman discusses the fallout from a North Carolina prescriber being told to surrender his DEA registration.

Statement on U.S. Drug Overdose Death Data

January 30, 2020
The Center for U.S. Policy’s Christopher Piemonte, Policy Manager, issued the following statement today in response to data released by the Centers for Disease Control and Prevention (CDC) on U.S. drug overdose deaths.

Experts Side with DEA on Opioid Quota Issue

January 20, 2020
Policymakers have been calling for the Drug Enforcement Administration (DEA) to reduce the number of opioids produced each year. Policy Manager Christopher Piemonte writes that experts in policy, pain, and law enforcement are all aligned in their belief that this strategy will be ineffective and that to continue to suggest it indicates a lack of education on the part of the policymakers.

Big Business, Congress Focus on Drugs

December 12, 2019

CUSP’s chairman discusses a major U.S. retailer’s theory that a rise in thefts may be attributed to the drug abuse crisis. He also discusses the proposed drug pricing bill before Congress.

Stakeholders Ask Congress for Hearings on SUPPORT Act Implementation

December 7, 2019
CUSP is a part of nine organizations that submitted a joint letter to Congress calling for oversight hearings on the implementation of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act.

Pain Doctor on DOJ Settlement: ‘It Was Extortion’

October 23, 2019

CUSP’s chairman discusses DOJ’s treatment of controlled-medication prescribers in the current climate. “Detailed medical records are the only affordable way for a provider to prove his innocence — or at least make the prosecutor think twice about proceeding with criminal charges.”

Opioid Pharma Hatred Doing More Harm Than Good

October 13, 2019
CUSP’s chairman discusses anti-opioid sentiment and its impacts on patients with persistent pain. “Everyone is going to be anti-opioid these days—until they have a car crash that breaks their pelvis, or a loved one gets cancer.”

Lawyer Calls for DOJ To End ‘Indiscriminate Raids’ of Prescribers

July 25, 2019

In recent years, the DEA has been increasing the number of raids on prescribers. CUSP’s chairman gives more insight into this rising problem.

As CBD Sales Boom, Consumers Need Clarity

July 14, 2019

Based on the assorted promotional claims of cannabidiol (CBD) product marketers, it appears that the truth about CBD’s benefits and risks depends on whom you ask and when.

Treatment Instead of Jail Can Save Lives, Reduce Costs

May 9, 2019

CUSP’s chairman discusses the benefits of policies that direct people with mental health or substance use disorders who commit minor crimes into treatment, not jail.

FDA Must Change Course on Addiction Treatment Medications

April 25, 2019

CUSP’s chairman discusses the Trump Administration’s opioid policies, warning that, unless the Food and Drug Administration changes its course, no new forms of the gold-standard medication for opioid addiction will come to market before 2024.

Three U.S. Crises Inextricably Linked

February 25, 2019

Three interconnected crises are currently happening in America: substance abuse, mental illness, and mass incarceration. All three can be curtailed by providing inmates with treatment and support during incarceration.

The Constitution, Compassion and Common Sense

December 20, 2018

Looking forward to the 2020 campaign cycle and beyond, the United States is facing three large national crises: substance abuse, mental illness, and mass incarceration. All of these can be addressed if we fulfill an obligation required of us not only by the Constitution, but also by compassion and common sense.

Ruling on Affordable Care Act ‘Deeply Flawed’

December 17, 2018

Michael Barnes discusses the judicial decision deeming the Affordable Care Act unconstitutional and the potential impacts on consumers and states.